TORONTO, ONTARIO--(Marketwire - November 11, 2008) - OccuLogix, Inc. (NASDAQ: OCCXD)(TSX: OC) announced that Dr. Richard Lindstrom, MD, today presented data demonstrating clinical performance, usability and safety data for the TearLab Osmolarity System. The data is derived from the recent 510(k) filing to the US Food and Drug Administration (the FDA) for clearance to market the TearLab™ Osmolarity System and the TearLab™ Osmolarity Test Card in the United States. Dr. Lindstrom is Adjunct Professor Emeritus for the University of Minnesota Dept. of Ophthalmology and is the Founder and Attending Surgeon at Minnesota Eye Consultants. Dr. Lindstrom serves on the Board of Directors of Occulogix.
